EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clonal Dissemination of NDM-Producing Proteus mirabilis in a Teaching Hospital in Sousse, Tunisia

Nadia Jaidane iD, Lamia Tilouche, Saoussen Oueslati, Delphine Girlich iD, Sana Azaiez, Aymeric Jacquemin, Laurent Dortet iD, Walid Naija, Abdelhalim Trabelsi, Thierry Naas iD, Wejdene Mansour, Rémy A Bonnin iD

Pathogens · 2025

DOI: 10.3390/pathogens14030298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Nadia Jaidane und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Metabolic Biophysics and Applied Pharmacology (LR12ES02), Department of Biophysics, Faculty of Medicine Ibn El Jazzar of Sousse, Univer…. Hauptthemen laut MEDLINE: Proteus mirabilis, beta-Lactamases, Proteus Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PHC Utique" program of the French Ministry of Foreign Affairs, the French Ministry of Higher Education, Research and Innovation and the Tunisian Ministry of Hi…, Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteus mirabilis (P. mirabilis) is an opportunistic pathogen involved in urinary tract infections as well as various nosocomial infections. Emerging resistances to beta-lactams in this species complicates potential treatment since it is intrinsically resistant to colistin. Eleven isolates of carbapenem-non-susceptible P. mirabilis were identified in Sousse Hospital, Tunisia, from January 2018 to December 2022. MICs were determined and isolates were sequenced to determine their resistomes, sequence types, virulence factors, and their clonal relationships. Susceptibility testing showed that all isolates were resistant to carbapenems, aminoglycosides, fluoroquinolones, chloramphenicol, and the trimethoprim/sulfamethoxazole combination. They remained susceptible to the aztreonam/avibactam combination. All isolates produced NDM-1 carbapenemase and ArmA 16S rRNA methylase. In addition, one isolate co-produced the blaVEB-6 gene. All isolates belonged to ST135, and phylogenetic analysis revealed that they were closely related. This study described the first outbreak of NDM-1-producing P. mirabilis in Tunisia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteus mirabilisbeta-LactamasesProteus InfectionsTunisiaHumansAnti-Bacterial AgentsMicrobial Sensitivity TestsHospitals, TeachingDrug Resistance, Multiple, BacterialPhylogenyMaleFemaleCross InfectionMiddle AgedAgedDisease Outbreaks

Stichwörter der Autor:innen

NDM-1VEB-6beta-lactamasecarbapenemasephylogeny

Substanzen

beta-Lactamasesbeta-lactamase NDM-1Anti-Bacterial Agents

Autor:innen und Institutionen

  • Laboratory of Metabolic Biophysics and Applied Pharmacology (LR12ES02), Department of Biophysics, Faculty of Medicine Ibn El Jazzar of Sousse, University of Sousse, Sousse 4000, Tunisia.
  • Clinical Microbiology Laboratory, University Hospital of Sahloul, Sousse 4002, Tunisia.
  • Team 'Resist', UMR1184 'Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB)', INSERM, Université Paris-Saclay, CEA, LabEx LERMIT, Faculty of Medicine, 94270 Le Kremlin-Bicêtre, France.
  • Faculty of Pharmacy, University of Monastir, Monastir 5000, Tunisia.
  • Faculty of Medicine Ibn El Jazzar, University of Sousse, Sousse 4000, Tunisia.
  • French National Reference Center for Antibiotic Resistance: Carbapenemase-Producing Enterobacterales, 94270 Le Kremlin-Bicêtre, France.

ORCID-Profile: Nadia Jaidane, Delphine Girlich, Laurent Dortet, Thierry Naas, Rémy A Bonnin

Förderung

  • PHC Utique" program of the French Ministry of Foreign Affairs, the French Ministry of Higher Education, Research and Innovation and the Tunisian Ministry of Hi…
  • Assistance Publique-Hôpitaux de Paris
  • Université Paris-Saclay
  • Institut National de la Santé et de la Recherche Médicale (INSERM)
  • French National Research Agency for the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT)
  • “PHC Utique” program of the French Ministry of Foreign Affairs
  • French Ministry of Higher Education, Research and Innovation
  • Tunisian Ministry of Higher Education and Scientific Research under the CMCU project

Zitieren

APA

Jaidane, N., Tilouche, L., Oueslati, S., Girlich, D., Azaiez, S., Jacquemin, A., Dortet, L., Naija, W., Trabelsi, A., Naas, T., Mansour, W., & Bonnin, R. A. (2025). Clonal Dissemination of NDM-Producing Proteus mirabilis in a Teaching Hospital in Sousse, Tunisia. Pathogens. https://doi.org/10.3390/pathogens14030298

Vancouver

Jaidane N, Tilouche L, Oueslati S, Girlich D, Azaiez S, Jacquemin A, et al. Clonal Dissemination of NDM-Producing Proteus mirabilis in a Teaching Hospital in Sousse, Tunisia. Pathogens. 2025. doi:10.3390/pathogens14030298

BibTeX
@article{Jaidane2025,
  author = {Jaidane, Nadia and Tilouche, Lamia and Oueslati, Saoussen and Girlich, Delphine and Azaiez, Sana and Jacquemin, Aymeric and Dortet, Laurent and Naija, Walid and Trabelsi, Abdelhalim and Naas, Thierry and Mansour, Wejdene and Bonnin, Rémy A},
  title = {Clonal Dissemination of NDM-Producing Proteus mirabilis in a Teaching Hospital in Sousse, Tunisia},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14030298}
}
Kostenlos starten →